Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $1.81 billion. The enterprise value is $1.26 billion.
Important Dates
The next estimated earnings date is Monday, May 4, 2026, after market close.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 178.73 million shares outstanding. The number of shares has increased by 20.10% in one year.
| Current Share Class | 178.73M |
| Shares Outstanding | 178.73M |
| Shares Change (YoY) | +20.10% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 57.43% |
| Float | 103.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 115.93 |
| Forward PS | n/a |
| PB Ratio | 3.04 |
| P/TBV Ratio | 3.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 81.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.61, with a Debt / Equity ratio of 0.06.
| Current Ratio | 22.61 |
| Quick Ratio | 21.68 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.12% and return on invested capital (ROIC) is -26.54%.
| Return on Equity (ROE) | -41.12% |
| Return on Assets (ROA) | -25.35% |
| Return on Invested Capital (ROIC) | -26.54% |
| Return on Capital Employed (ROCE) | -50.82% |
| Weighted Average Cost of Capital (WACC) | 12.91% |
| Revenue Per Employee | $79,974 |
| Profits Per Employee | -$1.44M |
| Employee Count | 192 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +202.74% in the last 52 weeks. The beta is 1.62, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +202.74% |
| 50-Day Moving Average | 8.87 |
| 200-Day Moving Average | 6.16 |
| Relative Strength Index (RSI) | 54.31 |
| Average Volume (20 Days) | 2,568,257 |
Short Selling Information
The latest short interest is 19.44 million, so 10.88% of the outstanding shares have been sold short.
| Short Interest | 19.44M |
| Short Previous Month | 19.89M |
| Short % of Shares Out | 10.88% |
| Short % of Float | 18.86% |
| Short Ratio (days to cover) | 8.34 |
Income Statement
In the last 12 months, RLAY had revenue of $15.36 million and -$276.48 million in losses. Loss per share was -$1.61.
| Revenue | 15.36M |
| Gross Profit | -244.15M |
| Operating Income | -302.74M |
| Pretax Income | -276.48M |
| Net Income | -276.48M |
| EBITDA | -299.18M |
| EBIT | -302.74M |
| Loss Per Share | -$1.61 |
Full Income StatementBalance Sheet
The company has $554.52 million in cash and $32.46 million in debt, with a net cash position of $522.06 million or $2.92 per share.
| Cash & Cash Equivalents | 554.52M |
| Total Debt | 32.46M |
| Net Cash | 522.06M |
| Net Cash Per Share | $2.92 |
| Equity (Book Value) | 567.06M |
| Book Value Per Share | 3.26 |
| Working Capital | 552.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$235.46 million and capital expenditures -$410,000, giving a free cash flow of -$235.87 million.
| Operating Cash Flow | -235.46M |
| Capital Expenditures | -410,000 |
| Free Cash Flow | -235.87M |
| FCF Per Share | -$1.32 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,971.59% |
| Pretax Margin | -1,800.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.10% |
| Shareholder Yield | -20.10% |
| Earnings Yield | -15.53% |
| FCF Yield | -13.25% |
Analyst Forecast
The average price target for RLAY is $16.14, which is 59.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.14 |
| Price Target Difference | 59.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 81.15% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 3.44 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.44 |
| Piotroski F-Score | 4 |
